share_log

Alliance Global Partners Maintains Buy on SELLAS Life Sciences Gr, Lowers Price Target to $8

Alliance Global Partners Maintains Buy on SELLAS Life Sciences Gr, Lowers Price Target to $8

Alliance Global Partners維持對Sellas Life Science Gr的買入,將目標價下調至8美元
Benzinga Real-time News ·  2022/11/15 08:12

Alliance Global Partners analyst James Molloy maintains SELLAS Life Sciences Gr (NASDAQ:SLS) with a Buy and lowers the price target from $14 to $8.

Alliance Global Partners分析師詹姆斯·莫洛伊維持賽拉斯生命科學公司(納斯達克:SLS)的買入態度,並將目標價從14美元下調至8美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論